Activity Background
International Opportunities At The Frontiers of Innovation
The 2024 Global Collaboration Summit on Innovative Drugs is an influential event in the field of international collaboration on innovative medicines co-organized by Deep Blue View, Boston Chinese Investment Mobilization Association, and Cyberland. It is held in San Diego, USA this year, during the BIO International Convention, which attracts global attention in the field of biomedicine. It mainly discusses technologies of innovative medicines, marketing strategies, business collaborations and other aspects. It also focuses on key topics such as pipelines of innovative medicines, productions of active pharmaceutical ingredients and services of CDMO to provide participants with insights in-depth and cutting-edge knowledge of the medicine field. At the same time, an international innovative medicine awards ceremony will be held to commend the winners for their outstanding achievements in Antibody discovery & ADC, siRNA & mRNA, raredisease & gene editing, neuron deases, Outstanding achievements in the fields of metabolism & drugs,AI&pharmaceutical and other fields.
Agenda
International Opportunities At The Frontiers of Innovation
June 2 ( Sun )
Afternoon Session（13:30-17:00）
| 13:30-14:00 | Roundtable Forum: Challenges and Opportunities of lnternational Cooperation on Pharmaceutical Companies Innovative Drug Pipelines ● Joan (Huaqiong) Shen, Founder & CEO, NeuShenTherapeutics |
| 14:00-14:30 | Experiences sharing in industrial upgrading ● Wenyu Luo, Associate Director & Business Development, Hansoh Pharma |
| 14:30-15:00 | The core of biopharmaceutical enterprise BD（provisional） ● Agustín de la Calle, Ph.D. Hinova Pharmaceuticals Inc. Executive Vice President, Business Development |
| 15:00-15:15 | Meeting Halftime |
| 15:15-15:45 | Panel Discussion I: Face-to-Face with Leading Overseas Lawyers: Common Legal Issues for Pharmaceutical Companies Going Globa ● Can Cui, PhD, JD, Partner at GoodWin, Co-leader of GoodWin Life Sciences practice in Asia ● Xin Tao, JD, Partner at Baker McKenzie, Government Regulatory and Enforcement |
| 15:45-16:30 | Panel Discussion II: Key to Success of Business Development for MNC: Strategies for Identification, Valuation and Transaction ● Jimmy Zhang, PhD, MBA Former Vice President, Transactions, J&J；Professor of Yeehong Business School；Executive Mentor of QB3/Bakar Labs ● Ms. Lili Zheng, Partner, Deloitte Tax LLP, Asia Pacific Cross-Border Services Leader ● Hui Huang, PhD, MBA, Drug Development Value & Access Expert, Founder & CEO, CSD-Partners, Former Vice President, Head of Global Value & Access Oncology · Takeda ● Leon Tang, PhD, Founding Partner of InScienceWeTrust BioAdvisory, Founder of InScienceWeTrust Community |
| 16:30-17:00 | Networking Hour |
Advantage
International Opportunities At The Frontiers of Innovation
Uniqueness
High specification
The whole industry chain
Pragmatic